TickerFacts.

BeOne Medicines Ltd. (ONC): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$286.48M
Year ended 2022-12-31
+59.1%
3-year compound annual growth
n/m
5-year compound annual growth
2016-12-31: $02017-12-31: $4.97M2018-12-31: $28.70M2019-12-31: $71.19M2020-12-31: $70.66M2021-12-31: $164.91M2022-12-31: $286.48M$286.48M
2016-12-31 Cost of Revenue (USD) 2022-12-31
Period endedCost of RevenueChange YoYSource filing
2022-12-31$286.48M+73.7%2023-02-27, From 2022-01-01
2021-12-31$164.91M+133.4%2023-02-27, From 2021-01-01
2020-12-31$70.66M-0.7%2023-02-27, From 2020-01-01
2019-12-31$71.19M+148.0%2022-02-28, From 2019-01-01
2018-12-31$28.70M+477.1%2021-02-25, From 2018-01-01
2017-12-31$4.97Mn/a2020-03-02, From 2017-01-01
2016-12-31$0n/a2019-02-28, From 2016-01-01